Article
A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance
2021-05-05
Abstract excerpt
More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to date. While determining the analytical sensitivity of the Quidel Sofia SARS Antigen FIA test (Sofia 2), we uncovered a h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bac6a073-9940-5427-a5a7-b6ba99a09ea5
- DOI
- 10.1101/2021.05.05.21256527
